Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

Get Started

Home
Investing
Stocks
Canada
TSXV
Quest PharmaTech Inc (QPT)
Quest PharmaTech Inc (QPT) News

QPT

Quest PharmaTech (QPT)

Quest PharmaTech Inc

Date:

Regulatory News

Text Search:

Sort by:

Non-Regulatory News

Showing the most relevant articles for your search:TSXV:QPT

<< Previous 1 2 3 4 Next >>

Date	Time	Source	Headline	Symbol	Company
04/22/2020	1:07PM	PR Newswire (Canada)	IIROC Trading Halt - QPT	TSXV:QPT	Quest PharmaTech Inc
04/22/2020	12:47PM	PR Newswire (Canada)	OncoQuest Signs a Definitive Agreement to Sell Drug Portfolio to Dual Industrial for U.S. $300 Million and Commitment to Fund...	TSXV:QPT	Quest PharmaTech Inc
03/24/2020	6:00AM	PR Newswire (Canada)	OncoQuest Announces Publication of Two Reports Related to Oregovomab Phase 2 Clinical Trial, the Company's Lead Investigation...	TSXV:QPT	Quest PharmaTech Inc
03/13/2020	5:01PM	PR Newswire (Canada)	OncoQuest Announces a U.S.$50 Million Investment by KOSDAQ listed Dual Industrial Co. Ltd.	TSXV:QPT	Quest PharmaTech Inc
09/25/2019	7:00AM	PR Newswire (Canada)	OncoQuest Receives "Notice of Allowance" for Patent Protection of the Administration Schedule of Oregovomab and Chemotherapy ...	TSXV:QPT	Quest PharmaTech Inc
01/29/2019	6:03PM	PR Newswire (Canada)	Quest PharmaTech Announces Results from AGM	TSXV:QPT	Quest PharmaTech Inc
01/25/2019	12:50PM	PR Newswire (Canada)	OncoQuest Lays the Groundwork for Commencement of Phase 3 Study in Frontline Ovarian Cancer	TSXV:QPT	Quest PharmaTech Inc
12/19/2018	7:26PM	PR Newswire (Canada)	Quest PharmaTech Adopts Amendment to By-laws Requiring Advance Notice of Nomination of Directors	TSXV:QPT	Quest PharmaTech Inc
12/03/2018	1:25PM	PR Newswire (Canada)	Quest PharmaTech Announces Adoption of Shareholder Rights Plan	TSXV:QPT	Quest PharmaTech Inc
11/28/2018	9:30AM	PR Newswire (Canada)	Quest PharmaTech Signs License Agreement with OncoCare Therapeutics to Develop and Commercialize Targeted Cancer Therapy Tech...	TSXV:QPT	Quest PharmaTech Inc
07/20/2018	4:30PM	PR Newswire (Canada)	Madenco Biosciences Announces Strategic Decision to Drop Consumer Health Products and Focus on Pharmaceutical Product Develop...	TSXV:QPT	Quest PharmaTech Inc
06/01/2018	7:30AM	PR Newswire (Canada)	Abstract Describing Use of Oregovomab in Pancreatic Cancer to be Published in JCO as Part of ASCO 2018 Meeting	TSXV:QPT	Quest PharmaTech Inc
05/14/2018	9:30AM	PR Newswire (Canada)	Dr. Eliel Bayever Joins OncoQuest as Chief Medical Officer	TSXV:QPT	Quest PharmaTech Inc
02/06/2018	9:30AM	PR Newswire (Canada)	OncoQuest Completes US$6 Million Private Placement	TSXV:QPT	Quest PharmaTech Inc
01/03/2018	9:30AM	PR Newswire (Canada)	Madenco Biosciences Announces Licensing Agreement for Patented EGF Wound Healing Technology	TSXV:QPT	Quest PharmaTech Inc
11/06/2017	11:39AM	PR Newswire (Canada)	Quest PharmaTech Announces Results from its November 2017 AGM	TSXV:QPT	Quest PharmaTech Inc
11/02/2017	1:13PM	PR Newswire (Canada)	OncoQuest Announces Collaboration with TESARO in Recurrent Ovarian Cancer Setting	TSXV:QPT	Quest PharmaTech Inc
08/28/2017	9:30AM	PR Newswire (Canada)	Quest PharmaTech Receives $1,666,667 of Funding Proceeds Through Exercise of Warrants	TSXV:QPT	Quest PharmaTech Inc
07/26/2017	9:30AM	PR Newswire (Canada)	First Patient Enrolled in OncoQuest's Phase 1/2 Study Combining Oregovomab with Hiltonol® in Recurrent Ovarian Cancer	TSXV:QPT	Quest PharmaTech Inc
07/19/2017	9:30AM	PR Newswire (Canada)	Quest PharmaTech Appoints Mr. Mark Lievonen, former President of Sanofi Pasteur Limited, to the Board of Directors	TSXV:QPT	Quest PharmaTech Inc
06/27/2017	9:47AM	PR Newswire (Canada)	OncoQuest Appoints Senior Biotech Investment Banker Hany Awadalla as Senior Vice President and Chief Financial Officer	TSXV:QPT	Quest PharmaTech Inc
06/27/2017	9:30AM	PR Newswire (Canada)	OncoQuest Appoints Senior Biotech Investment Banker Hany Awadalla as Senior Vice President and Chief Financial Officer	TSXV:QPT	Quest PharmaTech Inc
05/24/2017	9:30AM	PR Newswire (Canada)	OncoQuest to Present Oregovomab Phase II Interim Clinical Results for Front Line Treatment of Ovarian Cancer at the American ...	TSXV:QPT	Quest PharmaTech Inc
05/18/2017	7:00AM	PR Newswire (Canada)	Madenco Biosciences Creates New Line of Cosmeceuticals to Complement Bellus Skin™ Serum for Anti-Aging	TSXV:QPT	Quest PharmaTech Inc
05/09/2017	7:00AM	PR Newswire (Canada)	OncoQuest Announces Enrollment of First Patient in Phase 1/2 Clinical Study Using Combination of Oregovomab with Checkpoint I...	TSXV:QPT	Quest PharmaTech Inc
05/04/2017	11:34AM	PR Newswire (Canada)	Quest PharmaTech Expands Its Consumer Health Product Pipeline with Clinically Validated Natural Allergy Relief	TSXV:QPT	Quest PharmaTech Inc
02/15/2017	11:09AM	PR Newswire (Canada)	Quest PharmaTech Announces Results from its 2017 AGM	TSXV:QPT	Quest PharmaTech Inc
12/07/2016	4:31PM	PR Newswire (Canada)	OncoQuest Initiates Commercial Scale Oregovomab Manufacturing Program for Treatment of Ovarian Cancer	TSXV:QPT	Quest PharmaTech Inc
11/30/2016	9:32AM	PR Newswire (Canada)	L'OCRCVM permet la reprise de la négociation - QPT	TSXV:QPT	Quest PharmaTech Inc
11/30/2016	9:30AM	PR Newswire (Canada)	IIROC Trading Resumption - QPT	TSXV:QPT	Quest PharmaTech Inc

Showing the most relevant articles for your search:TSXV:QPT

<< Previous 1 2 3 4 Next >>

New Momentum (PK)

Cann American (CE)

RespireRx Pharmaceuticals (PK)

Therapeutic Solutions (PK)

Elite Pharmaceuticals (QB)

Rennova Health (PK)

Asia Broadband (PK)

Bell Buckle (PK)

Progressive Care (QB)

Gold and GemStone Mining (PK)

Delayed Upgrade Clock

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions